Press release
12.01.2021 To the attention of interested persons EMA press release: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine […]
Press release
08.01.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU […]
Press release
08.01.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine Moderna download document …
Press release
06.01.2021 To the attention of interested persons EMA press release: Update on rolling review of AstraZeneca’s COVID-19 vaccine download document […]
Press release
05.01.2021 To the attention of interested persons EMA press release: EMA public stakeholder meeting on COVID-19 download document … download […]
Press release
16.11.2020 To the attention of interested persons Nitrosamines: EMA aligns recommendations for sartans with those for other medicinal products download […]
Press release
22.10.2020 To the attention of interested persons EU authorities are investigating the presence of a nitrosamine impurity, 1-Nitroso-4-methyl piperazine (MeNP), […]
Press release
20.10.2020 To the attention of interested persons EU regulators require testing for nitrosamine impurities in metformin-containing medicinal products download document […]
Important notification
04.09.2020 To the attention of Romanian manufacturers/authorised representatives/importers The use of the EUDAMED “actors” registration module and of the single […]
Important notification
24.08.2020 To the attention of Contract Research Organisations In the context of the COVID-19 pandemic, the NAMMDR stated on 17.03.2020 […]